Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Nov 30, 2025 → Feb 28, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ERASCA INC | 0 | 169,487 | 169,487 | 1.45% | $2.32M |
| DAY ONE BIOPHARMACEUTICALS INC | 0 | 121,928 | 121,928 | 0.81% | $1.29M |
| TYRA BIOSCIENCES INC | 0 | 28,438 | 28,438 | 0.59% | $947.27K |
| ARRIVENT BIOPHARMA INC | 0 | 40,743 | 40,743 | 0.59% | $935.87K |
| MONTE ROSA THERAPEUTICS INC | 0 | 45,524 | 45,524 | 0.51% | $808.05K |
| COMPASS THERAPEUTICS INC | 0 | 127,476 | 127,476 | 0.45% | $720.24K |
| NATERA INC | 0 | 3,049 | 3,049 | 0.40% | $634.31K |
| ARVINAS INC | 0 | 45,326 | 45,326 | 0.38% | $601.48K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| DAIICHI SANKYO | 47,476 | 0 | -47,476 | 0.00% | -$1.17M |
| ENLIVEN THERAPEUTICS INC | 42,474 | 0 | -42,474 | 0.00% | -$917.44K |
| REPLIMUNE GROUP INC | 45,276 | 0 | -45,276 | 0.00% | -$452.76K |
| ASCENTAGE PHARMA GROUP INTERNATIONAL ADR | 10,385 | 0 | -10,385 | 0.00% | -$339.80K |
| SCHRODINGER INC | 17,733 | 0 | -17,733 | 0.00% | -$311.39K |
| PYXIS ONCOLOGY INC | 41,461 | 0 | -41,461 | 0.00% | -$215.18K |
| BRIDGEBIO ONCOLOGY THERAPEUTIC | 16,546 | 0 | -16,546 | 0.00% | -$203.68K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| Novartis AG (Registered) | 28,283 | 46,684 | 18,401 | 4.96% | $4.24M |
| BRIDGEBIO PHARMA INC | 63,618 | 114,318 | 50,700 | 4.76% | $3.02M |
| ASTRAZENECA PLC | 22,819 | 35,320 | 12,501 | 4.63% | $3.18M |
| LILLY ELI and CO | 5,636 | 6,565 | 929 | 4.32% | $844.97K |
| BRISTOL-MYERS SQUIBB CO | 50,429 | 108,187 | 57,758 | 4.22% | $4.27M |
| Roche Holding AG | 88,084 | 108,952 | 20,868 | 4.06% | $2.28M |
| MERCK & CO | 20,834 | 49,630 | 28,796 | 3.85% | $3.96M |
| ARCELLX INC | 34,712 | 48,346 | 13,634 | 3.44% | $2.98M |
| COGENT BIOSCIENCES INC | 100,480 | 135,358 | 34,878 | 3.29% | $1.22M |
| NUVALENT INC-A | 32,207 | 49,239 | 17,032 | 3.14% | $1.50M |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 122,429 | 169,724 | 47,295 | 3.13% | $1.03M |
| IMMUNOME INC | 85,272 | 195,451 | 110,179 | 2.67% | $2.70M |
| JOHNSON&JOHNSON | 12,691 | 16,257 | 3,566 | 2.53% | $1.41M |
| CELCUITY INC | 27,170 | 35,371 | 8,201 | 2.47% | $1.20M |
| AMGEN INC | 4,653 | 10,122 | 5,469 | 2.46% | $2.32M |
| ABBVIE INC | 11,054 | 16,712 | 5,658 | 2.43% | $1.36M |
| EXELIXIS INC | 67,581 | 79,639 | 12,058 | 2.20% | $523.84K |
| IDEAYA BIOSCIENCES | 78,259 | 89,238 | 10,979 | 1.80% | $85.88K |
| BEONE MEDICINES LTD ADR | 7,131 | 8,960 | 1,829 | 1.78% | $411.34K |
| SYNDAX PHARMACEUTICALS INC | 113,903 | 127,353 | 13,450 | 1.73% | $507.28K |
| CG ONCOLOGY INC | 31,845 | 45,885 | 14,040 | 1.69% | $1.27M |
| ZAI LAB LTD UNSPNRD ADR | 65,397 | 121,279 | 55,882 | 1.46% | $996.23K |
| ZYMEWORKS INC | 67,083 | 96,723 | 29,640 | 1.41% | $460.89K |
| LEGEND BIOTECH CORP SPON ADR | 57,468 | 115,409 | 57,941 | 1.37% | $600.33K |
| NUVATION BIO INC | 237,284 | 362,046 | 124,762 | 1.34% | $234.30K |
| HALOZYME THERAPEUTICS INC | 16,504 | 29,868 | 13,364 | 1.30% | $898.34K |
| CHUGAI PHARMA CO | 16,512 | 30,652 | 14,140 | 1.28% | $1.17M |
| SUMMIT THERAPEUTICS INC | 84,589 | 110,918 | 26,329 | 1.15% | $326.83K |
| ANAPTYSBIO INC | 19,947 | 28,657 | 8,710 | 0.99% | $746.78K |
| NURIX THERAPEUTICS INC | 67,655 | 97,555 | 29,900 | 0.98% | $361.81K |
| REGENERON PHARMACEUTICALS INC | 1,898 | 1,982 | 84 | 0.97% | $68.47K |
| CORVUS PHARMACEUTICALS INC | 62,382 | 82,148 | 19,766 | 0.94% | $927.98K |
| UROGEN PHARMA LTD | 53,158 | 67,164 | 14,006 | 0.91% | -$74.02K |
| RELAY THERAPEUTICS INC | 98,490 | 142,040 | 43,550 | 0.91% | $677.29K |
| OLEMA PHARMACEUTICALS INC | 39,318 | 56,608 | 17,290 | 0.86% | $256.43K |
| ARGENX SE SPONSORED ADR | 1,234 | 1,663 | 429 | 0.80% | $150.00K |
| TERNS PHARMACEUTICALS INC | 14,867 | 28,018 | 13,151 | 0.74% | $762.21K |
| XENCOR INC | 53,398 | 76,928 | 23,530 | 0.61% | $57.52K |
| GUARDANT HEALTH INC | 7,018 | 10,008 | 2,990 | 0.59% | $178.86K |
| ARCUS BIOSCIENCES INC | 31,913 | 45,953 | 14,040 | 0.59% | $103.13K |
| Immunocore Holdings plc ADS | 22,510 | 28,275 | 5,765 | 0.57% | $24.14K |
| HUTCHMED CHINA LTD ADR | 43,149 | 62,129 | 18,980 | 0.56% | $268.10K |
| CULLINAN THERAPE | 32,635 | 47,065 | 14,430 | 0.46% | $358.45K |
| JANUX THERAPEUTICS INC | 42,511 | 47,193 | 4,682 | 0.40% | -$806.90K |
| ORIC PHARMACEUTICALS INC | 24,617 | 35,407 | 10,790 | 0.30% | $183.77K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | 101,625 | 98,581 | -3,044 | 6.29% | $2.15M |
| GILEAD SCIENCES INC | 16,560 | 9,272 | -7,288 | 0.86% | -$702.85K |
| FIRST AM-TR OB-X | 1,672,347 | 1,026,901 | -645,446 | 0.64% | -$645.45K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.